Retrospective multi-reader evaluation of a deep learning-based cancer detection model in contrast-enhanced mammography
British Journal of Radiology · 2026-10-19
DOI: 10.1093/bjr/tqag252 ↗Abstract
Abstract Objectives To evaluate the clinical impact of a deep learning (DL)-based computer-aided diagnostic tool applied to contrast-enhanced mammography on radiologists’ diagnostic accuracy and reading efficiency. Methods In this retrospective single-center study, 150 contrast-enhanced mammography examinations were interpreted by 5 radiologists. Each case was read and annotated twice in 2 sequential sessions: first without assistance and then with the computer-aided diagnostic tool, with a minimum 4-week washout period. Diagnostic performance was assessed at lesion and breast levels using free-response receiver operating characteristic analysis, area under the curve, and false-positive rate. Reading time for 1 radiologist was recorded as an exploratory measure. Results The computer-aided diagnostic tool was associated with improved lesion-level performance for most radiologists, with a mean increase in the area under the free-response curve of 0.030 ± 0.018. At 89% sensitivity, false-positive findings decreased by an average of 11.4% ± 24% across all radiologists. No improvement was observed at the breast level, possibly related to the tool’s single-view analysis and dataset characteristics. An exploratory analysis showed a 31% reduction in reading time for 1 radiologist. Conclusions Integration of a DL-based computer-aided diagnostic tool into contrast-enhanced mammography was associated with improved lesion-level diagnostic performance and reduced false-positive findings, without measurable improvement at the breast level. Advances in knowledge To our knowledge, this study provides one of the early clinical evaluations of a DL-based computer-aided diagnostic tool for contrast-enhanced mammography, suggesting potential improvements in lesion-level diagnostic performance and workflow efficiency while highlighting current limitations at the breast level.
EUVIMED